Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Point of Care Molecular Diagnostics Market, by Product & Service
1.4.2 Europe Point of Care Molecular Diagnostics Market, by End User
1.4.3 Europe Point of Care Molecular Diagnostics Market, by Technology
1.4.4 Europe Point of Care Molecular Diagnostics Market, by Application
1.4.5 Europe Point of Care Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Europe Point of Care Molecular Diagnostics Market by Product & Service
4.1 Europe Assays & Kits Market by Country
4.2 Europe Instruments & Analyzers Market by Country
4.3 Europe Software & Services Market by Country
Chapter 5. Europe Point of Care Molecular Diagnostics Market by End User
5.1 Europe Physicians Offices Market by Country
5.2 Europe Hospitals & ICUs Market by Country
5.3 Europe Research Institutes Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Point of Care Molecular Diagnostics Market by Technology
6.1 Europe RT-PCR Market by Country
6.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Point of Care Molecular Diagnostics Market by Application
7.1 Europe Respiratory Diseases Market by Country
7.2 Europe Hospital-acquired Infections Market by Country
7.3 Europe Sexually Transmitted Diseases Market by Country
7.4 Europe Cancer Market by Country
7.5 Europe Hepatitis Market by Country
7.6 Europe Gastrointestinal Disorders Market by Country
7.7 Europe Others Market by Country
Chapter 8. Europe Point of Care Molecular Diagnostics Market by Country
8.1 Germany Point of Care Molecular Diagnostics Market
8.1.1 Germany Point of Care Molecular Diagnostics Market by Product & Service
8.1.2 Germany Point of Care Molecular Diagnostics Market by End User
8.1.3 Germany Point of Care Molecular Diagnostics Market by Technology
8.1.4 Germany Point of Care Molecular Diagnostics Market by Application
8.2 UK Point of Care Molecular Diagnostics Market
8.2.1 UK Point of Care Molecular Diagnostics Market by Product & Service
8.2.2 UK Point of Care Molecular Diagnostics Market by End User
8.2.3 UK Point of Care Molecular Diagnostics Market by Technology
8.2.4 UK Point of Care Molecular Diagnostics Market by Application
8.3 France Point of Care Molecular Diagnostics Market
8.3.1 France Point of Care Molecular Diagnostics Market by Product & Service
8.3.2 France Point of Care Molecular Diagnostics Market by End User
8.3.3 France Point of Care Molecular Diagnostics Market by Technology
8.3.4 France Point of Care Molecular Diagnostics Market by Application
8.4 Russia Point of Care Molecular Diagnostics Market
8.4.1 Russia Point of Care Molecular Diagnostics Market by Product & Service
8.4.2 Russia Point of Care Molecular Diagnostics Market by End User
8.4.3 Russia Point of Care Molecular Diagnostics Market by Technology
8.4.4 Russia Point of Care Molecular Diagnostics Market by Application
8.5 Spain Point of Care Molecular Diagnostics Market
8.5.1 Spain Point of Care Molecular Diagnostics Market by Product & Service
8.5.2 Spain Point of Care Molecular Diagnostics Market by End User
8.5.3 Spain Point of Care Molecular Diagnostics Market by Technology
8.5.4 Spain Point of Care Molecular Diagnostics Market by Application
8.6 Italy Point of Care Molecular Diagnostics Market
8.6.1 Italy Point of Care Molecular Diagnostics Market by Product & Service
8.6.2 Italy Point of Care Molecular Diagnostics Market by End User
8.6.3 Italy Point of Care Molecular Diagnostics Market by Technology
8.6.4 Italy Point of Care Molecular Diagnostics Market by Application
8.7 Rest of Europe Point of Care Molecular Diagnostics Market
8.7.1 Rest of Europe Point of Care Molecular Diagnostics Market by Product & Service
8.7.2 Rest of Europe Point of Care Molecular Diagnostics Market by End User
8.7.3 Rest of Europe Point of Care Molecular Diagnostics Market by Technology
8.7.4 Rest of Europe Point of Care Molecular Diagnostics Market by Application
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
9.10.1 Company Overview
Unique Offerings 
